BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33476605)

  • 1. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
    Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
    Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-146a-5p Inhibits Choroidal Neovascularization via the NF-κB Signaling Pathway by Targeting OTUD7B.
    Li L; Lai K; Gong Y; Huang C; Xu F; Li Y; Jin C
    Curr Eye Res; 2020 Dec; 45(12):1514-1525. PubMed ID: 32438838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
    Song JH; Moon KY; Lee SC; Kim SS
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin alleviates choroidal neovascularization by inhibiting proangiogenic factor production from infiltrating macrophages.
    Wang Y; Xie L; Zhu M; Guo Y; Tu Y; Zhou Y; Zeng J; Zhu L; Du S; Wang Z; Zhang Y; Liu X; Song E
    Exp Eye Res; 2021 Dec; 213():108823. PubMed ID: 34752817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirfenidone ameliorates the formation of choroidal neovascularization in mice.
    Bao Y; Huang L; Huang X; Gao C; Chen Y; Wu L; Zhu S; Song Y
    Mol Med Rep; 2020 May; 21(5):2162-2170. PubMed ID: 32323767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-vascular Endothelial Growth Factor Antibody Limits the Vascular Leakage and Decreases Subretinal Fibrosis in a Cynomolgus Monkey Choroidal Neovascularization Model.
    Inagaki S; Shimazawa M; Hamaguchi K; Otsu W; Araki T; Sasaki Y; Numata Y; Tsusaki H; Hara H
    Curr Neurovasc Res; 2020; 17(4):420-428. PubMed ID: 32445455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Andrographolide attenuates choroidal neovascularization by inhibiting the HIF-1α/VEGF signaling pathway.
    Cui K; Liu J; Huang L; Qin B; Yang X; Li L; Liu Y; Gu J; Wu W; Yu Y; Sang A
    Biochem Biophys Res Commun; 2020 Sep; 530(1):60-66. PubMed ID: 32828316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration.
    Lambert NG; Zhang X; Rai RR; Uehara H; Choi S; Carroll LS; Das SK; Cahoon JM; Kirk BH; Bentley BM; Ambati BK
    Exp Eye Res; 2016 Apr; 145():248-257. PubMed ID: 26775053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344.
    Xie P; Kamei M; Suzuki M; Matsumura N; Nishida K; Sakimoto S; Sakaguchi H; Nishida K
    PLoS One; 2011; 6(12):e28933. PubMed ID: 22205983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration.
    Narendran S; Pereira F; Yerramothu P; Apicella I; Wang SB; Varshney A; Baker KL; Marion KM; Ambati M; Ambati VL; Ambati K; Sadda SR; Gelfand BD; Ambati J
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):4. PubMed ID: 32749462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal imaging and electroretinography highlights the role of VEGF in the laser-induced subretinal fibrosis of monkey.
    Wang Y; Fang Q; Zhang C; Chen Y; Gou T; Cai Q; Yin H; Gao Y; Feng Y; Qiu S; Zhang M; Cen X; Zhang H; Chen D
    Exp Eye Res; 2021 Feb; 203():108417. PubMed ID: 33358768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing The Efficacy Of An Anti-Human VEGF-A Neutralizing Antibody Versus Bevacizumab On A Laser-Induced Choroidal Neovascularization (CNV) Rhesus Monkey Model.
    Olvera-Montaño O; Baiza-Duran L; Quintana-Hau JD; Quiñonez-Alvarado MG; Zeng W; Gong L; Muñoz-Villegas P
    Drug Des Devel Ther; 2019; 13():3813-3821. PubMed ID: 31806932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pigment Epithelium-Derived Factor as a Possible Treatment Agent for Choroidal Neovascularization.
    Xi L
    Oxid Med Cell Longev; 2020; 2020():8941057. PubMed ID: 32215180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept.
    Hong HK; Park YJ; Kim DK; Ryoo NK; Ko YJ; Park KH; Kim HM; Woo SJ
    Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):22. PubMed ID: 33196778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment.
    Hagbi-Levi S; Abraham M; Tiosano L; Rinsky B; Grunin M; Eizenberg O; Peled A; Chowers I
    J Immunol Res; 2019; 2019():8535273. PubMed ID: 31467935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of oxidative stress, inflammation and neovascularization in the choroid and retina in a subretinal lipid induced age-related macular degeneration model.
    Kim SY; Kambhampati SP; Bhutto IA; McLeod DS; Lutty GA; Kannan RM
    Exp Eye Res; 2021 Feb; 203():108391. PubMed ID: 33307075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitinase-3-Like-1 Promotes M2 Macrophage Differentiation and Induces Choroidal Neovascularization in Neovascular Age-Related Macular Degeneration.
    Xu N; Bo Q; Shao R; Liang J; Zhai Y; Yang S; Wang F; Sun X
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4596-4605. PubMed ID: 31675076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
    Romdhane K; Zola M; Matet A; Daruich A; Elalouf M; Behar-Cohen F; Mantel I
    Br J Ophthalmol; 2020 Jul; 104(7):910-916. PubMed ID: 31615761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection.
    Puranen J; Koponen S; Nieminen T; Kanerva I; Kokki E; Toivanen P; Urtti A; Ylä-Herttuala S; Ruponen M
    Exp Eye Res; 2022 Nov; 224():109237. PubMed ID: 36096189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel retinoic acid drug, EYE-502, inhibits choroidal neovascularization by targeting endothelial cells and pericytes.
    Shen Y; Xu M; Ren L; Li X; Han X; Cao X; Yao J; Yan B
    Sci Rep; 2023 Jun; 13(1):10439. PubMed ID: 37369771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.